The FDA has given its approval for the first test that could identify whether the Staphylococcus aureus bacteria is methicillin resistant (MRSA)

Clinical studies of the test on 1,116 blood samples found that it was 99.4 percent accurate in identifying MSSA infections and 98.9 percent accurate in identifying MRSA infections when Staphylococcus aureus bacteria was involved.
“The test not only saves time in diagnosing potentially life-threatening infections but also allows healthcare professionals to optimize treatment and start appropriate contact precautions to prevent the spread of the organism”, Alberto Gutierrez at the FDA's Center for Devices and Radiological Health said.
Source-Medindia
MEDINDIA




Email




